Innovative Strategies For Residual DNA And Viral Titre Quantitation

This webinar provides an in-depth exploration of the advantages of digital PCR (dPCR) in the context of biotherapeutic manufacturing, with a particular focus on the quantification of residual host cell DNA and viral titres. Gain valuable insights into how dPCR technology offers superior sensitivity, precision, and reproducibility compared to traditional methods. These attributes make it an essential tool for ensuring the quality and safety of biopharmaceutical products. Moreover, explore how the implementation of dPCR can streamline compliance with stringent regulatory standards, ultimately supporting more efficient and reliable manufacturing processes.

Whether you're involved in quality control, regulatory affairs, or process development, discover how dPCR can enhance your workflows and contribute to the production of safer, more effective therapeutics.